BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,476 Cr | ₹1,301 Cr | ₹1,212 Cr | ₹1,154 Cr | ₹1,109 Cr |
What is the latest Total Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,476 Cr |
| Mar2025 | ₹1,301 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹1,154 Cr |
| Mar2022 | ₹1,109 Cr |
How is Total Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,476 Cr | 13.43 | |
| Mar2025 | ₹1,301 Cr | 7.40 | |
| Mar2024 | ₹1,212 Cr | 5.03 | |
| Mar2023 | ₹1,154 Cr | 4.04 | |
| Mar2022 | ₹1,109 Cr | - | |
Compare Total Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹7,335.8 Cr | -1.9% | 26.5% | 343.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -1.9% |
26.5% |
343.8% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses